How to earn promotions in pharmaceutical industry

How to earn promotions in pharmaceutical industry Tue, 6 Sep 2005 In the world of pharmaceuticals, careers are made by marketing the worst products that cause the greatest harm. Contact: Vera Hassner Sharav 212-595-8974 XenoPort Appoints Gary D. Tollefson, Former Lilly Executive, to Board Company Snapshot: XNPThttp://www.xenoport.com SANTA CLARA, Calif.,…

14 deaths force halt to drug in Canada – Hyperactivity remedy called threat to kids

http://www.nj.com/news/ledger/index.ssf?/base/news-20/1108104141208160.xml Star-Ledger 14 deaths force halt to drug in Canada Hyperactivity remedy called threat to kids Friday, February 11, 2005 BY CAROL ANN CAMPBELL Safety concerns have clouded the future of another blockbuster medication, this one a hyperactivity drug prescribed to 700,000 Americans, most of them children. Health officials in…

Researcher Who Challenged ADHD industry cleared of misconduct charges

Researcher Who Challenged ADHD industry cleared of misconduct charges Sun, 16 Oct 2005 If you thought that academia could not prey to McCarthyite bullying tactics–or could not possibly fall prey to anything like the Salem witch hunts—think again. Dr. Gretchen LeFever, a clinical psychologist and associate professor in the department…

Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug

Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug Thu, 29 Sep 2005 Reuters reports that Eli Lilly is adding a Black Box suicide warning to the Strattera label. Strattera has been promoted as a “non stimulant” treatment for ADHD. Since ADHD…

Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children

Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children: "minimal risk" "minor increment of minimal risk" and "disorder or condition" January 28, 2001 A cornerstone of the Declaration of Helsinki (adopted by the World Medical Association in 1964, and reaffirmed on Oct. 2000) is the distinction between research…

FDA sends contradictory message re: addictive drugs for children – NIMH admits cognitive therapy as good as SSRIs

FDA sends contradictory message re: addictive drugs prescribed for children – NIMH admits cognitive therapy as good as SSRIs Fri, 27 May 2005 Two government health care agencies sent conflicting mixed messages about th euse of psychotropic drugs for children: The National Instiute of Mental Health issued an announcement acknowledging…

NY Times Whitewashes Ritalin Experiment in Preschool Kids

NY Times Whitewashes Ritalin Experiment in Preschool Kids Sat, 16 Nov 2002 A story in The New York Times magazine about a controversial government sponsored drug experiment avoids examining the tough issues. Instead, it describes the growing pains of an apparently normal 4 year old boy, Sam, whose parents enrolled…

212% Increase in Prescription Drug Abuse by US Teens – Australian critics challenge loose prescribers

212% Increase in Prescription Drug Abuse by US Teens – Australian critics challenge loose prescribers Tue, 27 Sep 2005 Psychiatric prescription drugs have “run amok”: two reports (July, August) by Columbia University’s National Center on Addiction and Substance Abuse, or CASA, confirm an epidemic of prescription drug abuse among teenagers:…

AHRP Files Court Brief to Protect Children from Harmful Research

October 1, 2001 Text of AHRP Amicus Brief filed with the Maryland Court of Appeals in support of the Court’s ruling against Kennedy Krieger Institute for exposing children to lead poison in an experiment. The Court of Appeals Decision Validates AHRP’s Stand Against Using Children in Harmful Research Experiments. ___________________________________________________…